Medicine Man Technologies Stock Performance
| SHWZ Stock | USD 0.10 0.04 78.57% |
Medicine Man holds a performance score of 10 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -5.78, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Medicine Man are expected to decrease by larger amounts. On the other hand, during market turmoil, Medicine Man is expected to outperform it. Use Medicine Man Technologies value at risk, kurtosis, and the relationship between the sortino ratio and semi variance , to analyze future returns on Medicine Man Technologies.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Medicine Man Technologies are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Medicine Man showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 1.2 M | |
| Total Cashflows From Investing Activities | -81.2 M |
Medicine |
Medicine Man Relative Risk vs. Return Landscape
If you would invest 20.00 in Medicine Man Technologies on September 13, 2024 and sell it today you would lose (10.00) from holding Medicine Man Technologies or give up 50.0% of portfolio value over 90 days. Medicine Man Technologies is currently generating 4.8272% in daily expected returns and assumes 37.2687% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Medicine, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Medicine Man Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medicine Man's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Medicine Man Technologies, and traders can use it to determine the average amount a Medicine Man's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1295
| Best Portfolio | Best Equity | SHWZ | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 37.27 actual daily | 96 96% of assets are less volatile |
Expected Return
| 4.83 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Medicine Man is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medicine Man by adding it to a well-diversified portfolio.
Medicine Man Fundamentals Growth
Medicine Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Medicine Man, and Medicine Man fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medicine Pink Sheet performance.
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0452 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 180.81 M | |||
| Shares Outstanding | 54.74 M | |||
| Price To Book | 0.47 X | |||
| Price To Sales | 0.49 X | |||
| Revenue | 108.42 M | |||
| EBITDA | 34.51 M | |||
| Cash And Equivalents | 33.86 M | |||
| Cash Per Share | 0.62 X | |||
| Total Debt | 97.48 M | |||
| Debt To Equity | 0.87 % | |||
| Book Value Per Share | 2.90 X | |||
| Cash Flow From Operations | 57.33 M | |||
| Earnings Per Share | (0.69) X | |||
| Total Asset | 285.03 M | |||
About Medicine Man Performance
Evaluating Medicine Man's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Medicine Man has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Medicine Man has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Medicine Man Technologies, Inc., doing business as Schwazze, operates as a cannabis company. The company was incorporated in 2014 and is headquartered in Denver, Colorado. Medicine Man operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 389 people.Things to note about Medicine Man Technologies performance evaluation
Checking the ongoing alerts about Medicine Man for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Medicine Man Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medicine Man is way too risky over 90 days horizon | |
| Medicine Man has some characteristics of a very speculative penny stock | |
| Medicine Man appears to be risky and price may revert if volatility continues | |
| Medicine Man has high likelihood to experience some financial distress in the next 2 years | |
| About 26.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Medicine Man's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medicine Man's stock is overvalued or undervalued compared to its peers.
- Examining Medicine Man's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medicine Man's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medicine Man's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medicine Man's pink sheet. These opinions can provide insight into Medicine Man's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Medicine Pink Sheet Analysis
When running Medicine Man's price analysis, check to measure Medicine Man's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicine Man is operating at the current time. Most of Medicine Man's value examination focuses on studying past and present price action to predict the probability of Medicine Man's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicine Man's price. Additionally, you may evaluate how the addition of Medicine Man to your portfolios can decrease your overall portfolio volatility.